DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Lefradafiban

Generic Name: Lefradafiban

Drug Type: Small Molecule

Chemical Formula: C_₂₃H_₂₅N_₃O_₆

CAS Number: 149503-79-7

Unique Ingredient Identifier: 0R4888YXR5

Overview

Lefradafiban is an oral platelet glycoprotein IIb/IIIa receptor antagonist being investigated in the treatment of angina.

Background

Lefradafiban is an oral platelet glycoprotein IIb/IIIa receptor antagonist being investigated in the treatment of angina.

Indication

For the treatment of unstable angina.

Associated Conditions

No associated conditions information available.

Clinical Trials

Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban Over 5 Days in Healthy Subjects

Phase 1

Completed

Posted: 2014/10/15

Sponsor:Boehringer Ingelheim

Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban in Healthy Subjects

Phase 1

Completed

Posted: 2014/10/15

Sponsor:Boehringer Ingelheim

Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects

Phase 1

Completed

Posted: 2014/10/15

Sponsor:Boehringer Ingelheim

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy